Skip to main content

Clinical Trials Using Hydroxychloroquine

Review the clinical trials studying hydroxychloroquine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-5 of 5

CPI-613 (Devimistat) in Combination with Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients with Advanced Chemorefractory Solid Tumors
Status: Active
Location: Northwestern University, Chicago, Illinois
Abemaciclib Alone or in Combination with Hydroxychloroquine for the Treatment of Patients with Breast Cancer, ABBY Trial
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Nivolumab and Hydroxychloroquine or Nivolumab, Ipilimumab, and Hydroxychloroquine for the Treatment of Stage III-IV Melanoma
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Status: Active
Location: See ClinicalTrials.gov
Autophagy Therapeutics (Hydroxychloroquine, Nelfinavir, Metformin, Dasatinib, and Sirolimus) for the Treatment of Advanced Solid Tumors or Relapsed Prostate Cancer
Status: Temporarily Closed to Accrual
Location: Medical University of South Carolina, Charleston, South Carolina